Evolution of the Average Target: West Pharmaceutical Services, Inc.

Evolution of the Target Price: West Pharmaceutical Services, Inc.

Changes in Analyst Recommendations: West Pharmaceutical Services, Inc.

27fac6cb4907.i_8gvegsdUaEqlK3n5WrzUI_GpBfsEBvSVsScI0OhhE.vaZv6bB4KnDKwgrlpsTd-SxHddUz8RI5JgxXFfh71UD5iELJpmUNLMXzYg~184b96accc3afbda6c0f6a2ecfd68ea7
23/09 West Pharmaceutical Poised to See EPS Upside to Current 2027 Wall Street Estimates, Morgan Stanley Says MT
22/09 Morgan Stanley Upgrades West Pharmaceutical Services to Overweight From Equalweight, Adjusts PT to $400 From $365 MT
09/09 UBS Raises Price Target on West Pharmaceutical Services to $415 From $340, Keeps Buy Rating MT
27/07 Evercore ISI Adjusts PT on West Pharmaceutical Services to $425 From $410, Maintains Outperform Rating MT
27/07 BNP Paribas Adjusts PT on West Pharmaceutical Services to $459 From $447, Maintains Outperform Rating MT
24/07 Jefferies & Co Adjusts West Pharmaceutical Services PT to $410 From $365, Maintains Buy Rating MT
24/07 Rothschild & Co Redburn Adjusts West Pharmaceutical Services PT to $410 From $353, Maintains Buy Rating MT
24/07 Deutsche Bank Adjusts West Pharmaceutical Services Price Target to $420 From $405, Maintains Buy Rating MT
20/07 Stephens Adjusts West Pharmaceutical Services Price Target to $410 From $360, Maintains Overweight Rating MT
16/07 TD Cowen Adjusts Price Target on West Pharmaceutical Services to $410 From $365, Maintains Buy Rating MT
14/07 BNP Paribas Initiates West Pharmaceutical Services at Outperform With $447 Price Target MT
13/07 BNP Paribas Initiates West Pharmaceutical Services at Outperform With $447 Price Target MT
10/07 Morgan Stanley Adjusts Price Target on West Pharmaceutical Services to $365 From $325 MT
06/07 Evercore ISI Adjusts Price Target on West Pharmaceutical Services to $410 From $390 MT
02/07 KeyBanc Adjusts PT on West Pharmaceutical Services to $390 From $350, Maintains Overweight Rating MT
09/06 Barclays Upgrades West Pharmaceutical Services to Overweight From Equalweight, Adjusts PT to $400 From $310 MT
28/05 Morgan Stanley Adjusts West Pharmaceutical Services PT to $325 From $315, Keeps Equalweight Rating MT
25/04 Stephens Adjusts Price Target on West Pharmaceutical Services to $360 From $320, Maintains Overweight Rating MT
24/04 Deutsche Bank Adjusts West Pharmaceutical Services PT to $340 From $315, Maintains Buy Rating MT
24/04 Rothschild & Co Redburn Adjusts West Pharmaceutical Services Price Target to $353 From $312, Maintains Buy Rating MT
24/04 Jefferies Adjusts West Pharmaceutical Services Price Target to $365 From $295, Maintains Buy Rating MT
24/04 Citigroup Adjusts West Pharmaceutical Services PT to $400 From $375, Maintains Buy Rating MT
24/04 Evercore ISI Adjusts West Pharmaceutical Services PT to $390 From $320, Maintains Outperform Rating MT
24/04 TD Cowen Adjusts West Pharmaceutical Services PT to $365 From $350, Maintains Buy Rating MT
24/04 Analyst recommendations: IBM, Intel, Tesla, AMD, United Rentals… Zonebourse

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
Average
Weighted average by Cap.


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
376.63USD
Average target price
407.56USD
Spread / Average Target
+8.21%
High Price Target
459.00USD
Spread / Highest target
+21.87%
Low Price Target
340.00USD
Spread / Lowest Target
-9.73%

Analyst Consensus Detail

Consensus revision (last 18 months)

Trader
Investor
Global
Quality
ESG MSCI
AAA
  1. Stock Market
  2. Stocks
  3. WST Stock
  4. Consensus West Pharmaceutical Services, Inc.